BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32169074)

  • 1. Gastrointestinal mixed adenoneuroendocrine carcinoma: a population level analysis of epidemiological trends.
    Wang J; He A; Feng Q; Hou P; Wu J; Huang Z; Xiao Z; Sun C; Liao W; Wu L
    J Transl Med; 2020 Mar; 18(1):128. PubMed ID: 32169074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed adenoneuroendocrine carcinoma originating from the appendix and colorectum: a comparative analysis of a large population-based database.
    Zhao B; Wang J; Ye H; Cheng X; Meng K; Yang T
    Tech Coloproctol; 2023 Nov; 27(11):1017-1024. PubMed ID: 36995458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends.
    Wang J; Li E; Yang H; Wu J; Lu HC; Yi C; Lei J; Liao W; Wu L
    World J Surg Oncol; 2019 Feb; 17(1):43. PubMed ID: 30813932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.
    Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I
    Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of colorectal mixed adenoneuroendocrine carcinoma and adenocarcinoma with neuroendocrine differentiation: a population-based study.
    Song LJ; Yuan L
    Int J Clin Exp Pathol; 2019; 12(3):922-932. PubMed ID: 31933902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis.
    Huang Z; Wang J; Zhang R; He A; Luo S; Wu R; Xiong J; Li M; Jin T; Li E; Wu L; Liao W
    Cancer Med; 2023 Apr; 12(8):9926-9936. PubMed ID: 36850060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed adenoneuroendocrine carcinoma (MANEC) of the lower gastrointestinal tract: A systematic review with Bayesian hierarchical survival analysis.
    Grossi U; Bonis A; Carrington EV; Mazzobel E; Santoro GA; Cattaneo L; Centonze G; Gallo G; Kazemi Nava A; Romano M; Di Tanna GL; Zanus G
    Eur J Surg Oncol; 2021 Nov; 47(11):2893-2899. PubMed ID: 34052038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic analysis and clinicopathological features of 20 patients with appendiceal neuroendocrine neoplasms].
    Mao W; Lyu Y; Pu N; Li J; Xin B; Chen W; Jin D; Lou W; Xu X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):564-568. PubMed ID: 29774940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of mixed adenoneuroendocrine carcinoma (MANEC) arising in Barrett's esophagus: literature and review.
    Kawazoe T; Saeki H; Edahiro K; Korehisa S; Taniguchi D; Kudou K; Nakanishi R; Kubo N; Ando K; Nakashima Y; Oki E; Fujiwara M; Oda Y; Maehara Y
    Surg Case Rep; 2018 May; 4(1):45. PubMed ID: 29740725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed adenoneuroendocrine carcinoma of the esophagogastric junction: a case report.
    Yamamoto M; Ozawa S; Koyanagi K; Oguma J; Kazuno A; Ninomiya Y; Yatabe K; Hatanaka K
    Surg Case Rep; 2018 Jun; 4(1):56. PubMed ID: 29900476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytological features of mixed adenoneuroendocrine carcinoma of the ampulla: two case reports with review of literature.
    Zhang L; DeMay RM
    Diagn Cytopathol; 2014 Dec; 42(12):1075-84. PubMed ID: 24554593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mixed adenoneuroendocrine carcinoma (MANEC) of the gastrointestinal tract].
    Šefr R; Němec L; Fabian P; Fiala L
    Rozhl Chir; 2017; 96(1):41-44. PubMed ID: 28325058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High neuroendocrine component is a factor for poor prognosis in gastrointestinal high-grade malignant mixed adenoneuroendocrine neoplasms.
    Chen MH; Kuo YJ; Yeh YC; Lin YC; Tzeng CH; Liu CY; Chang PM; Chen MH; Jeng YM; Chao Y
    J Chin Med Assoc; 2015 Aug; 78(8):454-9. PubMed ID: 26002564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): A single center case series.
    Dulskas A; Pilvelis A
    Eur J Surg Oncol; 2020 Jan; 46(1):105-107. PubMed ID: 31444026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality.
    Wu J; Sun C; Li E; Wang J; He X; Yuan R; Yi C; Liao W; Wu L
    BMC Cancer; 2019 Apr; 19(1):334. PubMed ID: 30961556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed adenoneuroendocrine carcinoma (MANEC) of the ampulla of Vater in a Chinese patient: A case report.
    Li X; Li D; Sun X; Lv G
    J Int Med Res; 2020 Aug; 48(8):300060520947918. PubMed ID: 32833541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed adenoneuroendocrine carcinoma: A review of pathologic characteristics.
    Brathwaite SA; Smith SM; Wai L; Frankel W; Hays J; Yearsley MM; Abdel-Misih S
    Hum Pathol; 2018 Mar; 73():184-191. PubMed ID: 29288693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic mixed adenoneuroendocrine carcinoma of the pancreas: A case report.
    Shimada N; Miwa S; Arai T; Kitagawa N; Akita S; Iinuma N; Ishii K
    Int J Surg Case Rep; 2018; 52():1-4. PubMed ID: 30292093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Mixed Adenoneuroendocrine Carcinoma(MANEC)of the Duodenum].
    Asakura Y; Yoshikawa T; Sakamoto H; Akashi T; Owada Y; Ienaga T; Ikura Y; Iwai Y
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2074-2076. PubMed ID: 28133226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appendiceal Mixed Adeno-Neuroendocrine Carcinoma: A Population-Based Study of the Surveillance, Epidemiology, and End Results Registry.
    Brathwaite S; Yearsley MM; Bekaii-Saab T; Wei L; Schmidt CR; Dillhoff ME; Frankel WL; Hays JL; Wu C; Abdel-Misih S
    Front Oncol; 2016; 6():148. PubMed ID: 27379210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.